Effect of iguratimod on diclofenac metabolism by CYP2C9 in rats and human recombinant CYP2C9 yeast cells. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 55, p. e17240, 2019. DOI: 10.1590/s2175-97902019000117240. Disponível em: https://revistas.usp.br/bjps/article/view/164525.. Acesso em: 2 may. 2024.